CN106361923A - Heart-nourishing and nerve-soothing pill for tachycardia - Google Patents
Heart-nourishing and nerve-soothing pill for tachycardia Download PDFInfo
- Publication number
- CN106361923A CN106361923A CN201610818080.0A CN201610818080A CN106361923A CN 106361923 A CN106361923 A CN 106361923A CN 201610818080 A CN201610818080 A CN 201610818080A CN 106361923 A CN106361923 A CN 106361923A
- Authority
- CN
- China
- Prior art keywords
- parts
- heart
- tachycardia
- nourishing
- pill
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000006187 pill Substances 0.000 title claims abstract description 16
- 208000001871 Tachycardia Diseases 0.000 title abstract description 19
- 230000006794 tachycardia Effects 0.000 title abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 38
- 210000002216 heart Anatomy 0.000 claims abstract description 30
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 230000002936 tranquilizing effect Effects 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920002472 Starch Polymers 0.000 claims abstract description 4
- 238000001035 drying Methods 0.000 claims abstract description 4
- 235000019698 starch Nutrition 0.000 claims abstract description 4
- 239000008107 starch Substances 0.000 claims abstract description 4
- 230000000213 tachycardiac effect Effects 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 4
- 241000222336 Ganoderma Species 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 5
- 208000019622 heart disease Diseases 0.000 abstract description 3
- 244000205574 Acorus calamus Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000011996 Calamus deerratus Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 240000008397 Ganoderma lucidum Species 0.000 abstract 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 235000013312 flour Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000003825 pressing Methods 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 206010010904 Convulsion Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000002861 ventricular Effects 0.000 description 4
- 206010047302 ventricular tachycardia Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000003734 Supraventricular Tachycardia Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000002324 minimally invasive surgery Methods 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000007674 radiofrequency ablation Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012373 Depressed level of consciousness Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000007888 Sinus Tachycardia Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010047289 Ventricular extrasystoles Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000002073 mitogenetic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- JWHAUXFOSRPERK-UHFFFAOYSA-N propafenone Chemical compound CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1 JWHAUXFOSRPERK-UHFFFAOYSA-N 0.000 description 1
- 229960000203 propafenone Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/882—Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A heart nourishing and mind tranquilizing pill for treating tachycardia, belonging to the technical field of medicines and aiming at solving the problem of treating tachycardia, is characterized by being prepared from the following traditional Chinese medicines according to the raw materials and the preparation method: firstly, the used traditional Chinese medicine raw materials: 15 parts of salvia miltiorrhiza, 15 parts of dogwood, 12 parts of amber, 13 parts of calamus, 20 parts of radix rehmanniae, 20 parts of magnetite, 15 parts of dens draconis, 20 parts of cowherb seed, 15 parts of honeysuckle, 15 parts of safflower, 15 parts of ligusticum wallichii, 10 parts of ganoderma lucidum, 8 parts of fructus trichosanthis and 7 parts of liquorice; secondly, the manufacturing method comprises the following steps: decocting the Chinese medicinal materials with clear water to obtain medicinal liquid, and concentrating the medicinal liquid at low temperature to obtain concentrated diluted paste; thirdly, mixing the concentrated diluted paste liquid with a proper amount of starch to form medicinal flour paste; and fourthly, pressing the medicinal powder paste into pills and drying the pills to form hard pills. The heart nourishing and mind tranquilizing pill for treating tachycardia is convenient to take, has quick response and is suitable for emergency self-rescue of patients with various heart diseases.
Description
Technical field
The present invention relates to treating tachycardic medicine, particularly to the medicine of traditional Chinese medical herbal treatment, belong to medical science skill
Art field.
Background technology
Tachycardia refers to be grown up heart rate per minute more than 100 times, two kinds of mitogenetic rationality, pathologic.Hyperpyrexia, anemia, hyperthyroidism,
The diseases such as bleeding, pain, anoxia, heart failure and cardiomyopathy cause tachycardia, rationality of pretending illness tachycardia；Run, drink, weighing body
Heart rate, referred to as physiological tachycardia when power is worked and is excited.
Pathologic tachycardia can be divided into sinus tachycardia and two kinds of paroxysmal supraventricular tachycardia again.Hole is aroused in interest
The feature overrun is increased heart rate and to turn be slowly all gradually to carry out, and heart rate generally per minute not over 140 times, be not in the mood for by majority
Dirty organic disease, generally no significant discomfort, sometimes there are the symptoms such as nervous, shortness of breath.Every point of paroxysmal supraventricular tachycardia
Up to 160～200 times, to break out and to stop suddenly being characterized, can betide heart has organic disease or nothing to clock heart rate
Heart organic disease person.During outbreak, patient feels suddenly nervous and increased heart rate, and last for several minutes, a few hours, to a couple of days, dash forward
So recover normal cardiac rate.During outbreak, patient feels that cardiopalmus, uncomfortable in chest, pareordia are uncomfortable and incidence is swollen, sense of beating.It is not in the mood for disease of ZANG-organs
The general moment-less influence of person, but duration of seizure is long, and when heart rate per minute is more than 200 times, because of blood pressure drops, patient occurs at the moment
Nigrescence, dizzy, weak and nausea and vomiting, or even unexpected faintness, shock.Tachycardia in patients with coronary artery disease, often induces
Angina pectoriss.
Heart ratess are too fast to be referred to as tachycardia.If tachycardia is so that it cannot maintain effective blood circulation
When, cardiopalmus, the quickly tachycardic symptom such as aroused in interest, chest pain, giddy, dizziness, stupor or semicoma can occur.Occur aroused in interest
When overrunning, the rhythm of the heart may rule or irregular beating.If quick heart beating originates from ventricle, referred to as ventricular tachycardia, can
Heart can be affected enough blood is pumped into brain and other vitals.First, the Electrocardiogram Feature of ventricular tachycardia is
Ventricular Rate often between 150 250 times/min, the roomy deformity of qrs ripple, the time limit is broadening, second, t ripple direction and the main ripple of qrs no ripple
On the contrary, no fixed relationship between p ripple and qrs ripple.Between the 3rd, q t, how normal the phase is, can be more common in many with q t interval prolongation
Shape room speed, the 4th, AR is slow compared with Ventricular Rate, visible ventricular fusion beats or ventricular capture sometimes.
Tachycardia in youngster, is because that hebetic vegetative nerve function is typically all unstable it is easy to occur
Disorder or functional disorder.But, this is temporary transient obstacle, is not necessary to special treatment, has crossed adolescence, and cardiopalmus are also with regard to spontaneous recovery.Blue or green
Though phase in spring tachycardia is not organic disease, when palpitating quickly, particularly heart rate exceedes 140 times per minute, is also very not
Comfortable, so tachycardia, when more than 120 times per minute, just should suitably be rested, take some and adjust vegetative nerve balance
Medicine.Below 120 times, typically it is not necessary to rest, suitably just permissible with a little medicines.
Tachycardic about remedy measures: Drug therapy and instrument treatment.Some medicines are to tachycardic of termination
There is temporal effect as effect, such as: propafenone, verapamil etc..But medicine is only temporary transient " termination " outbreak it is impossible to permanent
Radical cure, also have certain danger during medicine injection, Long-term taking medicine can neither definitely effectively prevent tachycardic send out again,
It is also harmful simultaneously.The method of radical cure is to rely on one kind safely and effectively Minimally Invasive Surgery radio-frequency ablation procedure.Control with medicine
Treatment is compared, and radio-frequency ablation procedure can disposably be effected a radical cure, and postoperative is no longer necessary to use antiarrhythmic drug；With surgical operation ratio, it
Do not need out breast and general anesthesia, patient's no pain, operational approach is easy.It is characterized in that wound is little, it is fast to recover, cure rate is high, postoperative
Can get up within 24 hours activity, just can leave hospital, and claim to effect a radical cure rapidly within postoperative 3 days, but the tachycardic cause of disease is complicated, dependence
The treatment of Minimally Invasive Surgery can not be put things right once and for all, and tachycardic outbreak is suddenly it is impossible to rely on instrument to hospital in time, must
The measure of saving oneself need to be taken in time.
Content of the invention
, just for tachycardic surface symptoms, old complaint must be cured, and the probability of recurrence is very for Western medicine and assistive device
Greatly.In order to overcome the limitation of Western medicine and assistive device, a kind of tachycardic medicine of my invention, taken with Chinese medicine
Treatment, and it is fabricated to pill, so that patient is taken in time and save oneself, effective quick.
With Chinese medicine viewpoint analysis tachycardia, belong to heart kidney deficiency, deficiency of both vital energy and Yin, malaise, treatment should be with temperature compensation kidney
Support essence, supplementing QI and nourishing YIN, suppressing the hyperactive liver promoting blood circulation, tranquilizing by nourishing the heart, the Chinese medicine combined therapy of soothing the channels and quicking the network vessels.According to upper analysis, for tachycardia
Tranquilizing by nourishing the heart ball solve problem adopted the technical scheme that and formed by the former reality of following each Chinese medicine and manufacture method: one, used
Raw material of Chinese medicine: 15 parts of Radix Salviae Miltiorrhizae, 15 parts of Fructus Corni, 12 parts of succinum, 13 parts of Rhizoma Acori Graminei, 20 parts of the Radix Rehmanniae, 20 parts of Magnetitum, white Dens Draconiss 15
Part, 20 parts of Semen Vaccariae, 15 parts of Flos Lonicerae, 15 parts of Flos Carthami, 15 parts of Rhizoma Chuanxiong, 10 parts of Ganoderma, 8 parts of Fructus Trichosanthis, 7 parts of Radix Glycyrrhizae；2nd, make
Method: each raw material of Chinese medicine and clear water are decocted into medicinal liquid and extracts medicinal liquid, the medicinal liquid cryoconcentration extracting is become to concentrate magma liquid；
3rd, it is mixed into powder mud by concentrating magma liquid with appropriate starch；4th, powder mud is pressed into pill and drying becomes hard pill.
Property of medicine efficiency analysis for each Chinese medicine in tachycardic tranquilizing by nourishing the heart ball: salviamiltiorrhizabung promoting blood flow to regulate menstruation, blood stasis dispelling
Pain relieving, cool blood to disappear carbuncle, relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.The anti-stress ability of Fructus Corni energy enhancing body, improves anoxia enduring, anti-tired
Labor ability, memory reinforcing.Fructus Corni can improve sod activity in erythrocyte, to anti peroxidation of lipid；Blood also drops in its ethanol extract
Fat acts on, it is possible to decrease serum triglycerides, the content of cholesterol, arteriosclerosis.Succinum tranquillizing the mind by relieving convulsion；Dissipate stasis of blood hemostasis；Diuretic
Treating stranguria；Removing nebula improving eyesight, for infantile convulsion, epilepsy, cardiopalmus.Rhizoma Acori Graminei effect: inducing resuscitation of having one's ideas straightened out, eliminating phlegm, ward off dirty, drying dampness to eliminate phlegm, wash
Expectorant, clear away heart-fire, tranquilizing the mind, be amusing, circulation of qi promoting stagnant.Radix Rehmanniae clearing away heat and promoting production of body fluid, removing heat from blood, yin nourishing, hemostasis, for consumption of YIN caused by febrile disease,
Crimson tongue excessive thirst, spot dermexanthesis, spit blood, epistaxis, laryngopharynx swelling and pain.Effect of Magnetitum and effect nature and flavor: Xin Xian；Flat；Nontoxic
Return through: kidney channel；Liver Channel；Lung meridian；Effect: suppressing the hyperactive liver and subsiding YANG；Calm the nerves relieving convulsion；Hearing-improing and eyesight improving；Helping inspiration to relieve asthma；Cure mainly: main dizziness；
Mesh is spent；Deaf；Tinnitus；Palpitation with fear；Insomnia.White Dens Draconiss are ancient times mammal fossil, cardiopalmus demented for infantile convulsion, insomnia.
Chinese medicine Semen Vaccariae can stimulate the menstrual flow in promoting the circulation of blood, expedites the emergence of stimulating milk secretion, healing up sore and subduing swelling.The potent medicine of Flos Lonicerae heat-clearing and toxic substances removing, antiviral, have green
The laudatory title of color antibiotic.Flos Carthami: promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving, controlling through closing, abdominal mass, difficult labour, stillborn fetuses, lochia is not
Row, blood stasis are had a pain, carbuncle, injury from falling down.Rhizoma Chuanxiong acrid in the mouth, warm in nature, Return liver, gallbladder, heart channel；The fragrant liter of gas dissipates, and cures mainly menoxenia,
Dysmenorrhea, amenorrhea, difficult labour, retention of placenta, lochia is suffered from abdominal pain, lump, heart pain in chest and hypochondrium, and traumatic injury swells and ache, dizziness of having a headache mesh
Secretly, anemofrigid-damp arthralgia.The major function of Fructus Trichosanthis is removing heat-phlegm, relieving stuffiness of the chest by dispersing aggregation of pathogens, moisturize laxation, detumescence and apocenosis.Fructus Trichosanthis are to cardiovascular
The effect of system has coronary artery dilating, resists myocardial ischemia, improves microcirculation.Radix Glycyrrhizae is the Chinese medicine applied simply widely, has
Many effects such as invigorating the spleen and replenishing QI, nourishing the lung to arrest cough, eliminating fire and detoxication, relieving spasm to stop pain, antiviral, coordinating the actions of various ingredients in a prescription.
Beneficial effect for tachycardic tranquilizing by nourishing the heart ball is: for, in tachycardic tranquilizing by nourishing the heart ball, inventing
People, with Chinese medicine viewpoint analysis tachycardia, belongs to heart kidney deficiency, deficiency of both vital energy and Yin, malaise, takes and supports essence, QI invigorating with temperature compensation kidney
Yin nourishing, suppressing the hyperactive liver promoting blood circulation, tranquilizing by nourishing the heart, the Chinese medicine composition of soothing the channels and quicking the network vessels is as medicine, and the decocting and concentrating liquid of medicine is added
Work is fabricated to pill, is easy to quickly take treatment, absorbs effective quick, that is, takes and take effect, and stable curative effect.
Specific embodiment
Below using the Traditional Chinese Medicine dosage of a box pill and manufacture method as embodiment to for tachycardic tranquilizing by nourishing the heart
Ball is further described.
For tachycardic tranquilizing by nourishing the heart ball ten dresses of one box pill be by the former reality of following each Chinese medicine and manufacture method and
Become: one, raw material of Chinese medicine used: 15 grams of Radix Salviae Miltiorrhizae, 15 grams of Fructus Corni, 12 grams of succinum, 13 grams of Rhizoma Acori Graminei, 20 grams of the Radix Rehmanniae, 20 grams of Magnetitum,
White 15 grams of Dens Draconiss, 20 grams of Semen Vaccariae, 15 grams of Flos Lonicerae, 15 grams of Flos Carthami, 15 grams of Rhizoma Chuanxiong, 10 grams of Ganoderma, 8 grams of Fructus Trichosanthis, Radix Glycyrrhizae 7
Gram；2nd, manufacture method: each raw material of Chinese medicine and clear water are decocted into medicinal liquid and extracts medicinal liquid, the medicinal liquid cryoconcentration of extraction is become dense
Contracting magma liquid；3rd, it is mixed into powder mud by concentrating magma liquid with appropriate starch；4th, powder mud is pressed into pill and change is dried
Become hard pill.Once take 3 ~ 4 when patient is urgent, with water delivery service, take ten minutes and take effect, tachycardia symptom can be alleviated,
Chew when patient takes tablet and water take effective faster.This medicine usage amount: patient takes said medicine one box, symptom for one day
With decrement or can cut out after stable.
The present invention is also applied for general heart disease for tachycardic tranquilizing by nourishing the heart ball, by many cases heart disease
People takes checking, treated effect 100%, controls cure rate 90%.
Claims (1)
1. it is used for tachycardic tranquilizing by nourishing the heart ball, it is characterized in that forming by the former reality of following each Chinese medicine and manufacture method: one, used
Raw material of Chinese medicine: 15 parts of Radix Salviae Miltiorrhizae, 15 parts of Fructus Corni, 12 parts of succinum, 13 parts of Rhizoma Acori Graminei, 20 parts of the Radix Rehmanniae, 20 parts of Magnetitum, white Dens Draconiss 15
Part, 20 parts of Semen Vaccariae, 15 parts of Flos Lonicerae, 15 parts of Flos Carthami, 15 parts of Rhizoma Chuanxiong, 10 parts of Ganoderma, 8 parts of Fructus Trichosanthis, 7 parts of Radix Glycyrrhizae；2nd, make
Method: each raw material of Chinese medicine and clear water are decocted into medicinal liquid and extracts medicinal liquid, the medicinal liquid cryoconcentration extracting is become to concentrate magma liquid；
3rd, it is mixed into powder mud by concentrating magma liquid with appropriate starch；4th, powder mud is pressed into pill and drying becomes hard pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610818080.0A CN106361923A (en) | 2016-09-13 | 2016-09-13 | Heart-nourishing and nerve-soothing pill for tachycardia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610818080.0A CN106361923A (en) | 2016-09-13 | 2016-09-13 | Heart-nourishing and nerve-soothing pill for tachycardia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106361923A true CN106361923A (en) | 2017-02-01 |
Family
ID=57897242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610818080.0A Withdrawn CN106361923A (en) | 2016-09-13 | 2016-09-13 | Heart-nourishing and nerve-soothing pill for tachycardia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106361923A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1745795A (en) * | 2004-09-08 | 2006-03-15 | 湖南德海制药有限公司 | Medicine for preventing and treating coronary heart disease and preparation method thereof |
| CN105055846A (en) * | 2015-09-20 | 2015-11-18 | 庞群 | Sick sinus syndrome and drug for treating same |
-
2016
- 2016-09-13 CN CN201610818080.0A patent/CN106361923A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1745795A (en) * | 2004-09-08 | 2006-03-15 | 湖南德海制药有限公司 | Medicine for preventing and treating coronary heart disease and preparation method thereof |
| CN105055846A (en) * | 2015-09-20 | 2015-11-18 | 庞群 | Sick sinus syndrome and drug for treating same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101254272B (en) | Medicament for promoting coronary circulation and embolism resistance | |
| CN104667047A (en) | Traditional Chinese medicine liquor for treating diabetic feet | |
| CN102114231B (en) | Medicine for treating arrhythmia | |
| CN103479969B (en) | A kind of medicine for the treatment of manic-depressive psychosis and preparation method thereof | |
| CN101637571B (en) | Traditional Chinese medicine preparation for treating heart cerebrovascular diseases and preparation method thereof | |
| CN103919910A (en) | Medicine for treating coronary heart disease | |
| CN102327436A (en) | Traditional Chinese medicine composition for treating edema during menstruation | |
| CN101554471B (en) | Traditional Chinese medicine preparation for treating myocardial infarction | |
| CN103933356A (en) | Preoperative intervention medicine composition for neurosurgery and preparation method of composition | |
| CN103610936A (en) | Chinese medicinal preparation for treating coronary heart disease and preparation method thereof | |
| CN103920005B (en) | Medicine is intervened before a kind of neurosurgery general anesthesia patients | |
| CN102641484A (en) | Preparation method of traditional Chinese medicine for treating qi-deficiency-type ecthyma | |
| CN106361923A (en) | Heart-nourishing and nerve-soothing pill for tachycardia | |
| CN103623365B (en) | Externally-applied medicine for rapid cardiac first aid and preparation method thereof | |
| CN103028088B (en) | Traditional Chinese medicine composition for treating coronary heart disease and angina | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN103893564B (en) | A kind of pharmaceutical composition suitable in the preoperative use of craniocerebral operations | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN102552863B (en) | Preparing method of traditional Chinese medicine lotion for treating the anorexia type ecthyma | |
| CN105709176A (en) | Traditional Chinese medicine composition for treating heart blood stasis type palpitation and preparation method thereof | |
| CN105267862A (en) | Traditional Chinese medicine composition for treating ventricular premature beat | |
| CN103845671A (en) | Powder for treating heart failure by warming yang and tonifying qi and preparation method thereof | |
| CN103977188A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN104367896A (en) | Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof | |
| CN103961677A (en) | Traditional Chinese medicine mixture for treating arrhythmia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170201 |
|
| WW01 | Invention patent application withdrawn after publication |